Market Research Blog – Page 15215 – New Product Development

Veterinary Imaging Market revenues will reach US$ 3.37 Billion by 2030

Global veterinary imaging market revenues will reach US$ 3.37 Bn by 2030, according to a study by Future Market Insights (FMI). The research study analyzes veterinary imaging market growth through 2030, in over 20+ countries. The study also offers incisive insights on key strategies of some of the leading players in the market.

According to the study, veterinary diagnostics market is witnessing investments, as pet humanization trend gains traction. Growing focus and government mandates on maintaining animal health is also likely to provide a boost to market growth.

The growth of the animal and pet care category as a whole will also spur growth. According to estimates from NAPHIA, the spending on pet food, pet insurance, and pet therapeutics have witnessed an increase in the recent past. The pet food category has in fact grown despite the Covid-19 crisis.

The broader gains in this market are likely to rub off on veterinary imaging market as well during the assessment period.

Key Takeaways

Animal healthcare being a costly affair, people are shifting their gears to pet insurance
The veterinary imaging market is driven by an ever-increasing number of veterinarians adopting imaging devices with reagents associated with them, which include PET, MRI, X-Ray radiology devices, and CT scanners
Multi-slice CT scan systems expected to drive the market in the forecast period
Asia-Pacific is slowly picking up with people turning the tide in favour of pet care
Adoption of magnetic resonance imaging (MRI) systems continue to grow at a steady pace

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12368

A Step Towards Better Future

In Aug 2020, the Veterinary Summer Scholars Symposium was held, which included 500+ veterinary students from all across the US, along with animal health leaders and researchers from close to 36 top veterinary schools.

This yearly scientific colloquium showcases research conducted by veterinary students who are on the verge of completion of summer research internships. Such symposiums are likely to compel more millennials to take up veterinary science in the due course of time.

“Technological advancements along with inorganic expansion are creating new strides for the veterinary imaging market. These trends are bound to catapult the veterinary imaging market to growth between 2020 and 2030”- says the FMI analyst.

Key Participant InsightsThe key market players are emphasizing on creating awareness about veterinary imaging devices to enter the untapped markets. For instance – in Oct 2018, GE Healthcare announced having inked a strategic agreement with SonoSim for encouraging training regarding ultrasound services.

The other players in the veterinary imaging market include Diagnostic Imaging System, Inc., Merry X-Ray, Carestream Health, Heska Corporation, Fujifilm Holding Corporation, Medical Imaging/IMCO, Inc., BCF, Esaote SpA.

Want more insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global veterinary imaging market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.

The study provides compelling insights on veterinary imaging market on the basis of product type (Equipment (Radiography (X-ray) System (Computed Radiography, Film-based Radiography)), Ultrasound Imaging System (2D US Imaging, 3D US Imaging), Magnetic Resonance Imaging System, Computed Tomography System (Single Slice CT, Multi-Slice CT), Video Endoscopy Imaging System, and Others)), Software, and Imaging Reagents (Ultrasound Contrast Reagents, MRI Contrast Reagents, X-Ray/CT Contrast Reagents, and Nuclear Imaging Reagents), application (Cardiology, Orthopedic, Neurology, Oncology, and Others), animal type (small animal, large animal), end-user (Veterinary Clinics, Veterinary Hospitals, and Veterinary Institutes and Research Centers) across seven geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12368

Key SegmentProduct Type

Equipment
Software
Imaging Reagent

Application

Cardiology
Orthopedics
Neurology
Oncology
Others

Animal Type

Small Animal
Large Animal

End-User

Veterinary Clinics
Veterinary Hospitals
Veterinary Institutes and Research Centres

Geography

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12368

Superficial Radiation Therapy Market is expected to reach US$ 57.3 Million by 2030

The global superficial radiation therapy market will reach US$ 57.3 Mn by 2030, according to a new report by ESOMAR-certified market research firm, Future Market Insights (FMI).

Superficial radiation therapy systems are being widely used as they prove to be an efficacious and non-invasive option with regards to skin treatment.

Also, superficial radiation therapy systems, based on almost negligible risks on the count of post-surgery infections and loads of other complications, are likely to gain further adoption in the future.

Consistency in terms of innovation has been the key focus area of the market players. For instance, Sensus Healthcare, in 2018, did install its SRT-100 system at “Hillcrest Plastic Surgery” in Orlando, Florida.

Keloid scars are being treated through this SRT-100. As an outcome of preference to these non-invasive procedures, the superficial radiation therapy systems market is expected to gain maximum mind share in the forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5279

Key Takeaways

The global superficial radiation therapy systems market is expected to reach US$ 39.7 Mn in 2020.
Ambulatory surgical centers are adopting superficial radiation therapy systems at a brisk pace
Curative treatment to lead the superficial radiation therapy systems market in the forecast period
Cancer treatment to tilt in favour of non-invasive treatment, which will ask for more innovations herein.

“Innovations on the consistent basis have been keeping the cash registers ringing. This trend is expected to propel the superficial radiation therapy systems market between 2020 and 2030” – says the FMI analyst.

Key Participant Insights

The global market is set to witness steady growth through 2030.

In addition to this, exploration of superficial radiation therapy systems for the other types of cancers like breast cancers (apart from skin cancers) is expected to drive the market.

The key market players covered by FMI include Sensus Healthcare, Inc., SkinCure, Mevion Medical Systems, Varian Medical Systems Inc., Ion Beam Applications, RaySearch Laboratories, Elekta AB, Mitsubishi Electric Corporation, IsoRay Inc., Xstrahl Ltd., and Nordion Inc.

At the same time, there is a dearth of medical professionals performing superficial radiation therapy with utmost precision. This factor is likely to hamper the market.

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global superficial radiation therapy systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on superficial radiation therapy systems market on the basis of product type (superficial radiation therapy systems, software), application (Basal Cell Carcinoma, Squamous Cell Carcinoma, Keloid scars, Psoriasis, Kaposi Sarcoma (Plaque Stage), Bowen’s Disease, Cutaneous T-cell Lymphoma, Soft Tissue Metastases), end-user (hospitals, ASCs (Ambulatory Surgical Centres), cancer research institutes, dermatology centres) across seven major regions.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5279

Key Segment

By Product Type

Superficial Radiation Therapy Systems
Superficial Radiation Therapy Software

By Application

Basal Cell Carcinoma
Squamous Cell Carcinoma
Keloid Scars
Psoriasis
Kaposi Sarcoma (Plaque Stage)
Bowen’s Disease
Cutaneous T-cell Lymphoma
Soft Tissue Metastases

By End User

Hospitals
Ambulatory Surgical Centers
Cancer Research Institutes
Dermatology Centers

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/5279

By Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

Patient Lateral Transfer Market is expected to witness a CAGR of over 7.1% between 2022 and 2030

As per FMI – an ESOMAR-certified market research firm, the global patient lateral transfer market is expected to reach US$ 519.3 Mn by 2030.

The likelihood of patients moving and getting lifted from stretchers or bed causing back injuries, strain to caregivers and healthcare workers owing to forceful exertion, repetitive movement, and awkward posture can’t be ruled out. Patient lateral transfer devices come to the rescue over here.

Patient lateral transfer devices lessen friction during transfer of patients and prove to be equally beneficial for patients.

Key Takeaways

Air-assisted transfer devices held the largest market share in 2019 and the winning streak is expected to continue in the forecast period
Asia-Pacific is looked upon as a promising market due to growing awareness about the need for patient lateral transfer devices along with improvement in healthcare infrastructure
Covid-19 to escalate the market in the year 2020, and further traction expected with the onslaught of chronic devices
Individual product promulgation is a key trend observed in the market

“The patient lateral transfer market is subject to exclusive branding by the key players. This trend coupled with the outbreak of Covid-19 is expected to propel the market in the forecast period” – FMI analyst.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12381

Key Participant Insights

The global patient lateral transfer market exhibits higher growth potential along with key players projecting their brands. The competitive factors include product differentiation, technology, and competitive pricing.

For instance – McAuley Medical’s Gold Rollboard, Patient Mover Slide Boards, and Handy Rollerboard Accessories, HoverMatt Air Transfer System from HoverTech, Himm-Rom’s HandyTube Manual Transfer Aid and Patient Transfer Board are doing the rounds at present.

The other players are also in the race. As such, there exists fierce competition over here. If players opt for partnerships/joint ventures, the competitive landscape would take a cutting-edge turn.

The players in the patient lateral transfer market include McAuley Medical, Inc., Patient Positioning Systems LLC, HoverTech International, Stryker Corporation (Sage Products LLC), Getinge AB (ArjoHuntleigh), EZ Way, Airpal, Inc., Arjo, Medline Industries, Haines Medical Australia, Sizewise, and Prism Medical.

FMI’s report offers incisive insights on the key strategies of leading and tier II patient lateral transfer market players. A detailed analysis of business and product strategies is offered in the report.

Want more insights?

The study provides compelling insights on patient lateral transfer market on the basis of product type (air-assisted transfer devices, slide sheets, and transfer accessories), usage type (single patient use, reusable), end-users (hospitals, clinics, ASCs) across seven regions.

Patient Lateral Transfer Market: Segmentation

The global Patient Lateral Transfer Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

air-assisted transfer devices
slide sheets
transfer accessories

Usage Type

single patient use
reusable

End-user

Hospitals
Cllinics
Ambulatory Surgical Centres

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12381

Geography

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Enteral Feeding Devices Market is predicted to expand at a CAGR of 6.6% over the forecast period 2022–2030

As healthcare infrastructure has improved, life expectancy has raised its bar. While this is welcome news, the rapidly proliferating geriatric population has also led to increased incidence of age-related ailments, both malignant and non-malignant. Conditions such as cancer, multiple sclerosis, dementia and brain damage have increased multifold.

All the aforementioned conditions have a deleterious impact on the patient’s digestive system, causing dyspepsia, throat and mouth pain, diarrhea and IBS. These co-morbidities render it impossible for patients to consume solid food. Hence, healthcare providers are accelerating the adoption of enteral feeding devices and provide adequate nutrients to patients.

Global Enteral Feeding Devices Market- Key Findings

Enteral feeding devices market to expand at 6.6% CAGR from 2020-2030
Oncology remains principal application area, neurological disorders to generate green spaces
Nasoenteric feeding tubes to share the revenue pie with feeding pumps, attributed to effectiveness of nutrient delivery
Homecare settings garnering major traction due to launch of easy-to-use and consumer friendly devices
East & South Asia will emerge as potential revenue hotspots during the forecast period

COVID-19’s Impact Analysis

The COVID-19 pandemic has prompted the healthcare industry to run into an overdrive mode, ceaselessly working to find a potential cure for this deadly virus. As the world economy heads toward a recession, the enteral feeding devices market shall remain afloat.

As infected patients experience digestive problems, the demand for alternative food administration sources has risen. This has upticked the deployment of enteral feeding device on an increased frequency. Additionally, vendors are concentrating on strengthening regional distribution networks to ensure uninterrupted supply of equipment to various healthcare settings and organizations.

Demand across the United States, Brazil and India will especially remain strong, given the fact that these are the worst affected countries, providing immense scope for revenue generation to prominent manufacturers.

“The global enteral feeding devices is in its growth stage, prompting vendors to flood the market with innovative and technologically advanced products, bringing the markets one step closer towards maturity,” infers the FMI analyst.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12403

Competitive Landscape

Prominent players in the enteral feeding devices market include ICU Medical, Boston Scientific Corporation, Fresenius Kabi, Abbott Laboratories, Cook Medical, Cardinal Health, Inc., Becton Dickinson & Company and Dynarex Corporation among others. Besides this, a number of regional players also dominate the landscape.

In 2014, Cook Medical launched the Entuit Thrive Balloon Retention Gastronomy Feeding Tube for gastronomy and gastropexy procedures. This launch was a part and parcel of the company’s efforts to expand its enteral feeding devices product pipeline.

Boston Scientific Corporation markets a broad range of enteral devices such as the EndoVive Enteral Feeding Tube Kits. To expand its gastroenterology product portfolio, the company announced a limited market release of its Exalt Model-D single-use duodenoscope in January 2020.

In 2016, Cardinal Health launched its Kangaroo Joey Enteral Feed and Flush Pump to expand its adult nasogastric feeding tubes portfolio.

ICU Medical markets the Lopez Valve and EnFit Lopez Valve Closed Enteral Tubes which provide protection from accidental exposure to infectious body fluids to healthcare workers.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12403

Enteral Feeding Devices Market: Segmentation

Product Type

Enteral Feeding Pumps
Enteral Feeding Tubes
Enterostomy Feeding Tubes
Standard Tubes
Standard Gastrostomy Tubes
Standard Jejunostomy Tubes
Standard Gastrojejunostromy Tubes
Low Profile Tubes
Low-profile Gastrostomy Tubes
Low-profile Jejunostomy Tubes
Nasoenteric Feeding Tubes
Nasogastric Feeding Tubes
Nasojejunal Feeding Tubes
Nasoduodenal Feeding Tubes
Oroenteric Feeding Tubes
Administration Sets
Enteral Syringes
Consumables

Application

Oncology
Gastroenterology
Diabetes
Neurological Disorders
Others

Age Group

Adult
Pediatric

End-user

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Homecare Settings
Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12403

Region

North America
Latin America
Europe
East Asia
South Asia
Middle East & Africa

Physiotherapy Equipment Market is set to expand at a CAGR of 7.2% during 2022-2030

[300 Pages Report] According to FMI, the global physiotherapy equipment market is set to expand at a CAGR of 7.2% during 2020-2030. Rising geriatric population, combined with heightened levels of physical inactivity among the younger population is inducing several orthopedic and muscular disorders. Over 1 billion people worldwide lead extremely sedentary lifestyles according to the WHO.

The increasing levels of physical inactivity is leading to various problems such as frozen joints, muscle degeneration, sprains and strains have compounded, necessitating the need for physiotherapy. Additionally, rising incidences of road and sports accidents is acting as a catalyst for increasing the number of physiotherapy procedures.

Based on these trends, manufacturers are concentrating on introducing technologically advanced products and introducing them into the market at highly competitive prices. Additionally, specific nature of injuries is prompting them to dole out specific products. Majority of the players are scrambling to acquire a footing across emerging economies.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12409

Physiotherapy Equipment Market Study- Key Findings

Ultrasound physiotherapy equipment shall tower over others, attributed to rising demand for non-invasive surgeries

Musculoskeletal devices shall pivot the market in terms of application throughout 2020-2030

North American market accounts for over 2/5th of the revenue

East & South Asia remain lucrative, jointly capturing nearly 1/4th of the revenue share

“Prevalence of co-morbidities amongst the geriatric population has made physiotherapy a top priority for them, prompting vendors to introduce technologically sophisticated equipment in order to provide the elderly major relief from the pain induced by various physical ailments,” infers the FMI analyst.

COVID-19’s Impact on the Physiotherapy Equipment Market

The COVID-19 pandemic has ushered in an era of major uncertainty. As the global economy hurtles towards a major recession, the physiotherapy equipment market will experience significant shortfalls. As the pandemic intensifies, elective surgical procedures are being postponed, thus reducing demand for physiotherapy equipment in hospitals.

Moreover, residential visits by physiotherapists have reduced in the wake of maintaining social distancing. Since they utilize such equipment during these sessions, the decline in these visits has ushered in sluggishness in demand. On the supply side, unavailability of raw materials has halted production.

A recovery is expected in the initial quarters of 2021, when the infection curves flatten. Many countries such as Australia & New Zealand are already exhibiting decline in infection rates, thus heightening growth prospects and keeping the market afloat.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-12409

Competitive Landscape

The global physiotherapy equipment market is characterized by the presence of several prominent players who are concentrating on introducing new products and acquisitions to carve a firm footing.

In June 2020, DJO Global introduced the DonJoy X-ROM Post-Op Knee Brace, incorporating an improvised user-friendly fastener which is easy to adjust and easy to apply. In 2019, the company launched the first fully sterile surgeon-controlled leg and retractor holder for Anterior Approach Hip Arthroplasty.

In 2017, U.S Physical Therapy Inc. successfully acquired a Houston-based local physical therapy practice at a purchase price of US$ 11.4 million, with the practice’s clinical owners retaining 30% of the stake. The acquisition was announced in 2016.

Key Segment

Equipment Type

Cryotherapy

Hydrotherapy

Electrotherapy

Continuous Passive Motion Units

Multi-exercise Therapy Unit

Heat Therapy

Ultrasound Physiotherapy

Other Therapy Types

Application

Neurological

Musculoskeletal

Cardiovascular and Pulmonary

Others

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/12409

End-user

Hospitals

Rehabilitation Centers/Clinics

Homecare Settings

Region

North America

Latin America

Europe

Middle East & Africa (MEA)

East Asia

South Asia

Oceania

Transcutaneous Oximetry Systems Market 2022 by Applications, Key Players, By Technology, Application Types and Production Information Analysis and Forecast 2028

In terms of geography, the market has been divided into seven regions including North- America, Eastern Europe, Western Europe, and Asia- Pacific excluding & Japan (APEJ), Japan, Middle-East & Africa, and Latin America. North America is the most dominating market for transcutaneous oximetry systems market due to the growing adoption of advanced monitoring systems and high demand for screening provide to avoid complications. Western European expected to contribute the second largest revenue share in transcutaneous oximetry systems market owing to rising demand for advanced monitoring devices. The Asia Pacific excluding Japan transcutaneous oximetry systems market is expected to gain a high growth rate over the forecast period due to increasing healthcare expenditure and healthcare infrastructure development.

This Transcutaneous Oximetry Systems market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Transcutaneous Oximetry Systems market.

Transcutaneous oximetry systems are used to perform transcutaneous oximetry (TCPO2) test. Transcutaneous oximetry systems measure oxygen at the skin surface, which is a valuable pointer to know how much oxygen gets to the underlying tissue. Transcutaneous oximetry systems primarily used to access the severity of artery diseases and measure blood & oxygen flow usually in legs and arms. Transcutaneous oximetry systems are help physician to determine poor blood flow in several tissues. Transcutaneous oximetry tests are especially carried out to predict wound healing or amputation healing. Transcutaneous oximetry systems can be used in several clinical areas for routine measurements such as determination of peripheral vascular diseases and amputation level, evaluation of revascularization procedures, and candidate selection for hyperbaric oxygen therapy. Transcutaneous oximetry allows the measurement of the partial pressure of oxygen on the skin surface by employing non-invasive heated electrode.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-9194

Transcutaneous Oximetry Systems Market: Drivers and Restraints-

Transcutaneous oximetry systems market is expected to accounts significant growth rate as increasing prevalence of peripheral vascular disorders and wound healing disorder. According to Centre of Disease Control & Prevention, Around 8.5 million people in the United States have peripheral vascular disorders. Moreover, the increasing prevalence of diabetic foot ulcer is propelling the demand for transcutaneous oximetry systems. As well as transcutaneous oximetry systems are also gaining popularity to check need of amputation. Diabetic foot ulcer is the major reason for foot amputation. Growing adoption advanced monitoring systems for blood flow monitoring expected to favor the demand of the transcutaneous oximetry systems. Increasing demand for technologically advanced products is expected to propel the growth of the transcutaneous oximetry systems market. Increasing aging population and healthcare expenditure expected to boost the growth of transcutaneous oximetry systems market. Growing demand for non-invasive blood flow monitoring systems and sensor-based systems expected to flourish the growth of transcutaneous oximetry systems market.

Transcutaneous Oximetry Systems Market: Overview

Transcutaneous oximetry systems are non-invasive monitoring systems. Transcutaneous oximetry systems are consists of combined platinum and silver electrode. Transcutaneous oximetry systems are increasingly popular to assess wound healing and amputation level during hyperbaric oxygen treatment. Transcutaneous oximetry systems are used to perform transcutaneous oximetry in adult and neonatal. Transcutaneous oximetry systems are gaining popularity in the market as used in the various application as wound healing, peripheral vesicular disorders, hyperbaric oxygen therapy, and amputation level determination. Transcutaneous oximetry systems offer real-time monitoring and ideal for monitor pCO2, SpO2, blood flow rate, and pulse rate.

Transcutaneous Oximetry Systems Market: Key Market Participants

Example of some market players participants in global transcutaneous oximetry systems market identify across the value chain are

Radiometer America Inc.
Perimed AG
Koninklijke Philips N.V.
SenTec AG
medicap homecare GmbH
Radiology Inc. and others.

The manufacturer is focusing on the launch of new products for expansion of market presence and revenue growth.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-9194

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (India, China ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Transcutaneous Oximetry Systems Market: Segmentation

On the basis of product type, transcutaneous oximetry systems market can be segmented as:

Vascular Diagnosis & Wound Healing Monitor
Neonatal Monitoring Systems
Others

On the basis of diagnostic application, transcutaneous oximetry systems market can be segmented as:

Peripheral Vascular Disease Diagnosis
Amputation Level Determination
Revascularization Procedures Evaluation
Hyperbaric Oxygen Therapy

On the basis of end user, transcutaneous oximetry systems market can be segmented as:

Hospitals
Clinics
Ambulatory Surgical Centers
Diagnostic Centers

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/9194

Neurovascular Access Catheters Market 2022 Outlook, Current and Future Industry Landscape Analysis 2025

Immunochemistry analyzer are becoming more and more popular in the global clinical chemistry and immunoassay as these are proved to be very effective tool to diagnose cancer, hepatitis, illegal drugs, fertility problems, sodium levels, endocrine function, and the detection of blood clots.

There are approximately more than 180,000 immunochemistry analyzers were installed globally in 2013. Out of which only about 17-20% of these analyzers are installed in the United States. This statistic suggests that the markets like China, India, and Japan where there is lack of basic lab facility prevails are adopting this new technology .Also it’s been seen that the recurring consumable sales are a strong factor to segment growth.

Immunochemistry analyzers are instruments that automatically run tests on samples from patients to detect any number of biologically active substances .It is very important to know which analyzer to use as different analyzers have different analysis time, and need different reagents which make these instrument highly sophisticated. These analyzers are mainly being used in infectious disease testing, cancer, cardiac, and autoimmune diseases.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9189

Immunochemistry Analyzer Market: Drivers and Restraints

Under the strong rules & regulation laboratories find it difficult to have good revenues. Thus it’s very important to find ways to sustain in such a cost-crunched environment. Due to the cost cutting in clinical lab fees, profitability per test is decreasing which makes it necessary for the laboratories to focus on the volume rather than the value. There is also heavy pressure for quality, error-free results to ensure patient satisfaction. This forces labs to lean toward more automated systems with effective workflow solutions.

In US, Laboratories are encouraged for automation due to the heavy influx of patients with insurance coverage. But with limited workforce in the clinical lab it’s difficult to manage the huge inflow of patients. On the other hand patients need prompt & error free results. Thus this scenario demands laboratories to seek the help of systems that have a high accuracy, with managing high growing volumes and also offer remote data acquisition capabilities. The automated analyzers working with barcode readers, rack detection systems, and sample/plate identification modules to avoid plate or sample switch.

Immunochemistry Analyzer Market : Overview

With the rapid technological advancement in healthcare industry the immunochemistry analyzer market is expected to grow at a healthy CAGR in the forecasted period (2015-2025).

Globally, the immunochemistry market represents approximately 40.1% of the global in vitro diagnostics (IVD) market. Immunochemistry is by far the largest segment by volume, mostly due to routine testing. It is primarily driven by growing access to healthcare.

Immunochemistry Analyzer Market : Region-wise Outlook

Depending on geographic region, global immunochemistry analyzer market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

Demand for immunochemistry analyzers is slowing in the US and Western and Eastern Europe. Europe’s challenges in this segment include laboratory consolidation in France and economically troubled Greece, Italy, Spain, and Portugal. China’s growing rural hospital market lacks basic diagnostics laboratory infrastructure and represents an untapped opportunity for affordable immunochemistry analyzers.

Immunochemistry Analyzer Market : Key Players

The market is fully fragmented with leading brands, such as Siemens, Abbott Diagnostics, Beckman Coulter, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc. and F. Hoffmann-La Roche Ltd.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-9189

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes

North America (U.S., Canada)

Latin America (Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC, S. Africa)

Immunochemistry Analyzer Market:Segmentation

Immunochemistry analyzer market is segmented into following types:

Instruments

Reagents

Global immunochemistry analyzer Market, by Instrument Type

Instruments

Immunochemistry Analyzers

Chemiluminescence Immunoassay (CLIA) Analyzers

Immuno Fluorescence (IFA) Analyzers

Enzyme Immunoassay (EIA) Analyzers

Radioimmunoassay (RIA) Analyzers

Enzyme Linked Fluorescent Assay (ELFA) Systems

Multiplexed Assay Systems

Immunochemistry Stainers

Automated Stainers

Semi-Automated Stainers

Global Immunochemistry analyzer Market, By Application

Endocrinology

Oncology

Cardiology

Therapeutic Drug Development & Monitoring

Infectious Disease Testing

Drugs Of Abuse Testing

Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-9189

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

Dental Floss Market to Witness Excellent Revenue Growth, Overview, Emerging Trends and Forecast by 2028

Dental floss is an essential part of maintaining healthy teeth. Dental floss is used to remove plaque, all food particle, and film of bacteria which stuck between teeth and impossible to remove from the toothbrush. It is accessible in ribbon or string form, which can be and waxed or un-waxed. Dental floss also available in several flavours to attract children about flossing. Dental floss is available in flavours such as mint, cinnamon, bubble-gum, and plain. Nowadays, disposable floss is gaining traction among young children who may be less able to clean floss. Increasing interest among people to adopt preventive healthcare measures is expected to drive the demand for dental floss. Moreover, increasing adoption of oral care products is expected to favour the growth of the dental floss market. Moreover, various organization such as the American Dental Association are recommended the use of dental flossing minimum once in a day to get rid of plaque.

Dental Floss Market: Drivers and Restraints-

Growing spending on dental and oral products to avoid dental surgeries will drive the growth of the dental floss market. Increasing interest in preventive health care across the world will increase the demand for dental care products such as dental floss. Growing disposable income and healthcare expenditure favours the growth of the dental floss market. The increasing demand for dental care products to prevent dental diseases such as periodontal disease, dental plaque, and oral infection. Increasing adoption of new treatment and care options impel the growth of the dental floss market. Availability of new preventive dental care products is another major factor expected to propel the growth of the dental floss market. Increasing dentist recommendations to include flossing in daily routine propel the growth of the dental floss market over the forecast period. Moreover, dental care regulatory organizations such as the European Federation of Periodontology, American Dental Association, and the National Health Service recommended the use of dental floss in health policies. High awareness regarding dental care and the availability of flavoured dental floss drives the growth of the dental floss market near the future. Increasing sales of dental floss by e-commerce channel is another major trend in the dental floss market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-8442

Dental Floss Market: Overview

Flossing is the key part of the oral hygiene which helps to prevent from a various dental problem. Dental floss generally available as un-waxed floss, waxed floss, dental tape, polytetrafluoroethylene (PTFE) floss, and super floss. Waxed dental floss is available with additional coating of wax on tread or ribbon. Waxed dental flosses compare to un-waxed dental floss as the lesser chance of gum injury compare to un-waxed dental flosses. Moreover, dental floss is easily available at online and retail stores which will turn into faster market growth near the future.

Dental Floss Market: Region-wise Outlook

In terms of geography, the dental floss market has been divided into seven regions including North- America, Eastern Europe, Western Europe, and Asia- Pacific excluding & Japan (APEJ), Japan, Middle-East & Africa, and Latin America. North America is the most dominating market for dental floss market due to high consumption of dental floss in the U.S. market around 50% of demand come from the U.S. market. North contribute high revenue share as high awareness regarding oral hygiene and increasing dentist recommendation. Western European expected to contribute second largest revenue share in dental floss market due to the rise in disposable income and high demand for new dental care products. The Asia Pacific excluding Japan dental floss market is expected to gain a high growth rate over the forecast period due to changing lifestyle, increasing healthcare spending and dental care awareness.

Dental Floss Market: Key Market Participants

Example of some market players participants in global dental floss market identify across the value chain are Procter & Gamble Company, Colgate-Palmolive, Johnson & Johnson, Sunstar Suisse SA, Prestige Consumer (DenTek Oral Care Inc.), DR. Fresh Inc. , Lion Corporation (Japan), Church & Dwight Co., Inc., Shantou Oral Health Co. Ltd. and others.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-8442

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (India, China ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Dental Floss Market: Segmentation

On the basis of product type, dental floss market can be segmented as:

Waxed Floss
Unwaxed Floss
Others

On the basis of the end user, the dental floss market can be segmented as:

Hospitals
Dental Clinics
Home Care

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/8442

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Patient-Controlled Injectors Market By Product, By Technology, By Application, By Region, And Segment Forecast 2022 – 2028

With the advent of drug delivery system, new technologies have evolved for betterment of patient ease and comfort aiding patient compliance, safety and adherence. Recent innovations such as patient-controlled injectors is booming the market and thus many companies focus on developing patient controlled delivering systems and wearable injectors. Patient-controlled injectors spur an important innovations in injectable administration of drugs. Ergonomically developed and design patient-controlled injectors can help in optimizing self-care making it easy for patients to hold the system and administer the dosages at just one press. Patient-controlled injectors enables the patient to control the dosage rate by their own which as a result reduces the pain unlike spring-based auto-injectors. Thus new development in science and technology has made new innovation for greater ease and comfort for patients.

Patient-Controlled Injectors: Market Dynamics

Patient-controlled injectors is expected to grow simultaneously in the market owing to greater ease and comfort for administration of injections which as a result will gain significant popularity among people. In addition to this, controlled release of the patient-controlled injectors helps the patient to administration the injection by own and helps them to decide their own dosage rate. All these factors may drive the global patient-controlled injectors market. Besides, the patient-controlled injectors can be administered at home settings and thus there occurs increase in demand of the patient-controlled injectors. Many manufacturers are now focused on developing patient-controlled injectors to meet the unmet needs and so the patient-controlled injectors is stimulating the growth of the market. However, lack of awareness about the patient-controlled injectors may hamper the growth of the market.

Patient-Controlled Injectors Market: Overview

Patient-controlled injectors is the latest innovation in administration of injections. There occurs high unmet needs of patients requiring the patient-controlled injectors as it has greater ease and comfort as compared to spring-based auto-injectors. For example, in 2019, Janseen has received FDA approval of Tremfya one-press patient-controlled Injector for the treatment of patient with Plaque Psoriasis. One-Press is design to help the patient to control the pressure and the rate of the injection. Apart from this, West Pharmaceutical Services, Inc has also developed self-dose patient-controlled injectors which provide an off-the-shelf delivery system which is optimally design for drug administration in patients. Self-dose patient-controlled injectors is designed with a prefilled 1ml syringe with a system of passive needle safety. Thus with the latest innovation in injections, patient-controlled injectors is likely to anticipate the growth of the market in coming years.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9301

Patient-Controlled Injectors: Region-wise Outlook

On the basis of geography, the global patient-controlled injectors market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa. North America is projected to hold the substantial share in the patient-controlled injectors market due to increasing adoption of new technologies and rising healthcare expenditure. Europe market spur to have high growth in patient-controlled injectors market due to advancement in technology and adoption of new devices. Asia Pacific is also potentially stimulating the growth of the patient-controlled injectors market due to increasing awareness among people and demand for new treatment options. Japan has the potential to grow the overall patient-controlled injectors market due to increasing healthcare infrastructure and innovation in technologies. Middle East & Africa have less impact in overall patient-controlled injectors market due to lack of proper healthcare infrastructure and lack of awareness about new treatment may hamper the patient-controlled injectors market.

Patient-Controlled Injectors Market: Key Players

Some of the key players present across the value chain of the global patient-controlled injectors market are West Pharmaceutical Services, Inc, Janssen Pharmaceutical, Westbourne Medical Ltd.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain

The regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Patient-Controlled Injectors Market: Segmentation

The global patient-controlled injectors market is segmented by distributional channel.

Segmentation by Distributional Channel

Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/9301

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance

Liver Fluke Treatment Market 2022 End-User Demand by Types, Regions, Service Provides, Regional Outlook and Forecast to 2028

Liver Fluke is defined by the condition affected by the infection causing worms. The liver fluke is generally categorized in 2 types by infection causing worms and termed as Fasciola hepatica and Fasciola gigantica. Many a times the liver fluke infection goes undiagnosed or misdiagnosed with common abdominal pain. The liver fluke denies the pathway of common worm’s infection transmitting from one person another. The available liver fluke treatment is based on the anthelmintic effects the drug exert in the body. Another liver fluke treatment line is permitted by the government and CDC is oral triclabendazole where’s the WHO have listed he drug as an essential drug and it is still not approved in some parts of US. The liver fluke treatment regimen also follows the use of the Bithionol and nitazoxanide for the removal of worms for the liver although a surgical intervention and in some cases a worm removal surgery is essential due to infection to bile duct.Liver Fluke Treatment Market: Drivers and Restraints

Rapidly expanding research studies and growing incidence of infection in humans and cattle. Research on the development of the dedicated drug for Liver Fluke Treatment following with increasing availability of Symptomatic Liver Fluke Treatment. Is anticipated to fuel the Liver Fluke Treatment market. Furthermore, government organization on raising awareness on liver fluke, fascioliasis and Liver Fluke Treatment drug is signifying the growth of the Liver Fluke Treatment market. The surge in the fascioliasis prevalence and incidence rate is estimated as the major factor for the growth of the Liver Fluke Treatment market owing to the higher rate of liver fluke in wetlands and related emergency room visits. The essential medicine status for the Liver Fluke Treatment drug triclabendazole is anticipated to offer new growth opportunities for the Liver Fluke Treatment market. However, complexity in dose preparation and adjustment for Liver Fluke Treatment drugs and requirement of long treatment cycles is anticipated the restraint the growth of the Liver Fluke Treatment market.

Liver Fluke Treatment Market: Overview

The Liver Fluke Treatment market displays the monopoly of single manufacturer and are primarily focused on delivering free medicines under the WHO tie up with the manufacturer. As per the data from the Novartis approximately 41 million worth of drug is donated and utilized by the 2 million people all around the world. The drug provided by the Novartis Egaten is the only approved medication for the of liver fluke treatment in human can animals although a veterinary substitute is available for the triclabendazole. Egaten is the widely used medication and listed in the WHO model essential medicines list. The liver fluke is more prevalent in the developing regions and wetland due to poor sanitary conditions. The growing intensity of the infection spread is anticipated to fuel the demand for liver fluke treatment drug. Subsequently aiding to increase the liver fluke treatment market. Due to rare nature of infection and government aid new manufacturers are queuing up for the entry in the liver fluke treatment market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9298

Liver Fluke Treatment Market: Region-Wise Overview

The global Liver Fluke Treatment market is segmented into the following regions – North America, Latin America, Europe, East Asia, south Asia, Oceania and the Middle East & Africa. East Asia is the leading regional market for Liver Fluke Treatment due to the increasing incidence of liver fluke, fasciola hepatica. Additionally symptomatic Liver Fluke Treatment demand in the region. In East Asia, china is dominating Liver Fluke Treatment market due to increasing awareness for fasciola hepatica and rising beef and seafood use in the country. Latin America Liver Fluke Treatment market is anticipated to grow significantly higher owing to higher incidence in Peru and Bolivia. South Asia is a growing at significant rate owing to growing awareness initiatives form government in Liver Fluke Treatment. Growth in North America and the Europe is considerably low due to low incidence rate and higher sanitization parameters in the regions.

Liver Fluke Treatment Market: Key Participants

Examples of some of the key participants in the Liver Fluke Treatment market are Novartis, GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc, Bayer HealthCare Pharmaceuticals Inc., Par Pharmaceutical, Romark Laboratories, L.C., Lupin Pharma, Schering Corporation among others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Liver Fluke Treatment Market Segments
Liver Fluke Treatment Market Dynamics
Liver Fluke Treatment Market Size
Liver Fluke Treatment Market Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

The regional analysis includes:

North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East & Africa

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Liver Fluke Treatment Market: Segmentation

Based on Drug Type, the Liver Fluke Treatment market is segmented into:

Triclabendazole
Praziquantel
Bithionol
Nitazoxanide
Albendazole

Based on Application, the Liver Fluke Treatment market is segmented into:

Human
Cattle
Sheep

Based on Distribution Channel Liver Fluke Treatment market is segmented into:

Government healthcare centers
Hospital Pharmacies
Retail pharmacies
Online Pharmacy

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9298

Report Highlights:

A detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size regarding volume and value
Recent industry trends and developments
Competitive landscape
Strategies for key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint